Document Detail


Arterial calcifications.
MedLine Citation:
PMID:  20716128     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Arterial calcifications as found with various imaging techniques, like plain X-ray, computed tomography or ultrasound are associated with increased cardiovascular risk. The prevalence of arterial calcification increases with age and is stimulated by several common cardiovascular risk factors. In this review, the clinical importance of arterial calcification and the currently known proteins involved are discussed. Arterial calcification is the result of a complex interplay between stimulating (bone morphogenetic protein type 2 [BMP-2], RANKL) and inhibitory (matrix Gla protein, BMP-7, osteoprotegerin, fetuin-A, osteopontin) proteins. Vascular calcification is especially prevalent and related to adverse outcome in patients with renal insufficiency and diabetes mellitus. We address the special circumstances and mechanisms in these patient groups. Treatment and prevention of arterial calcification is possible by the use of specific drugs. However, it remains to be proven that reduction of vascular calcification in itself leads to a reduced cardiovascular risk.
Authors:
Roger J M W Rennenberg; Leon J Schurgers; Abraham A Kroon; Coen D A Stehouwer
Related Documents :
20075848 - Association of interleukin-18 levels with global arterial function and early structural...
20410618 - Waveform of ophthalmic artery doppler flow predicts the severity of systemic atheroscle...
22329828 - Carotid-jugular fistula diagnosed by transesophageal echocardiography.
20021528 - The relationship between flow-mediated dilatation of the brachial artery and intima-med...
24717458 - Extravascular lung water, b-type natriuretic peptide, and blood volume contraction enab...
24383668 - The last shot for "one shot" pulmonary vein isolation with radiofrequency energy?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cellular and molecular medicine     Volume:  14     ISSN:  1582-4934     ISO Abbreviation:  J. Cell. Mol. Med.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-11-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101083777     Medline TA:  J Cell Mol Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  2203-10     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.
Affiliation:
Department of Internal Medicine, Maastricht University Medical Centre (MUMC+) and Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands. r.rennenberg@mumc.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium.
Next Document:  Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to lon...